Literature DB >> 31618740

Paeoniflorin on Rat Myocardial Ischemia Reperfusion Injury of Protection and Mechanism Research.

Fubin Wu1, Binhua Ye1, Xiandan Wu1, Xian Lin1, Yanyan Li1, Yongning Wu1, Linping Tong2.   

Abstract

OBJECTIVE: To study the myocardial benefit effect and mechanism of paeoniflorin on myocardial ischemia reperfusion injury (MIRI) in rats.
METHODS: Hundred SD rats were randomly divided into 5 groups: sham group, model group, Paeoniflorin (15 mg/kg) group, Paeoniflorin (30 mg/kg) group, and Paeoniflorin (60 mg/kg) group. Myocardial ischemia reperfusion model was established in each group except the sham group. The myocardial infarction and morphological changes were measured by the TTC staining and HE staining respectively. Myocardial caspase-3 was detected by immunohistochemistry. In addition, the protein levels of Bcl-2 and Bax and the expression ratio of p-erk, p-jnk, and p-p38 were detected by Western blot. Myocardial superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were measured by the assay kit.
RESULTS: Paeoniflorin (30 mg/kg) and Paeoniflorin (60 mg/kg) can obviously alleviate myocardial infarction caused by MIRI (p < 0.05). HE staining showed that the myocardial morphology in the treatment group was obviously better than that in the model group. WB and immunohistochemistry showed that Paeoniflorin (30 mg/kg) and Paeoniflorin (60 mg/kg) can significantly increase the reduced protein level of bcl-2 (p < 0.05) and reduce the increased protein level of caspase3, bax -p-erk, p-jnk, and p-p38 caused by MIRI (p < 0.05). The activity of SOD was increased and the level of MDA was decreased after Paeoniflorin treatment.
CONCLUSION: Paeoniflorin preconditioning has a protective effect on MIRI in rats. Its mechanism is related to reducing oxidative stress and apoptosis by inhibiting the expression of apoptosis-related signaling pathway.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Anti-inflammatory; Antiapoptotic; Antioxidant; Myocardial ischemia reperfusion injury; Paeoniflorin

Mesh:

Substances:

Year:  2019        PMID: 31618740     DOI: 10.1159/000503583

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  9 in total

Review 1.  Recent Insights Into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases.

Authors:  Feng Jiao; Kevin Varghese; Shaoxun Wang; Yedan Liu; Hongwei Yu; George W Booz; Richard J Roman; Ruen Liu; Fan Fan
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

2.  Lycium barbarum polysaccharides inhibit ischemia/reperfusion-induced myocardial injury via the Nrf2 antioxidant pathway.

Authors:  Jin-Jun Liu; Gong-Xiao Zhao; Lei-Lei He; Zheng Wang; Abdoulaye Issotina Zibrila; Bai-Chun Niu; Hao-Yu Gong; Jing-Ning Xu; Lynn Soong; Chun-Fang Li; Yi Lu
Journal:  Toxicol Rep       Date:  2021-03-24

Review 3.  Effects and Mechanisms of Taohong Siwu Decoction on the Prevention and Treatment of Myocardial Injury.

Authors:  Chang-Le Shao; Guo-Hong Cui; Hai-Dong Guo
Journal:  Front Pharmacol       Date:  2022-01-26       Impact factor: 5.810

4.  An Integrated Approach Based on Network Analysis Combined With Experimental Verification Reveals PI3K/Akt/Nrf2 Signaling Is an Important Way for the Anti-Myocardial Ischemia Activity of Yi-Qi-Tong-Luo Capsule.

Authors:  Huxinyue Duan; Meiyan Li; Jia Liu; Jiayi Sun; Chunjie Wu; Yu Chen; Xiaohui Guo; Xinglong Liu
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

5.  Asiatic Acid Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting the ROS-Mediated Mitochondria-Dependent Apoptosis Pathway.

Authors:  Chenlong Yi; Meijuan Song; Lifu Sun; Linjie Si; Dongmin Yu; Ben Li; Peng Lu; Wei Wang; Xiaowei Wang
Journal:  Oxid Med Cell Longev       Date:  2022-02-14       Impact factor: 6.543

Review 6.  Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases.

Authors:  Xiuli Cheng; Jin Hu; Xiaofeng Liu; Jonnea Japhet Tibenda; Xiaobo Wang; Qipeng Zhao
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

7.  Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats.

Authors:  Li-Li Hong; Yan Zhao; Wei-Dong Chen; Chen-Yu Yang; Guo-Zhuan Li; Hong-Song Wang; Xiao-Yu Cheng
Journal:  Front Cardiovasc Med       Date:  2022-09-14

8.  Guanxin V attenuates myocardial ischaemia reperfusion injury through regulating iron homeostasis.

Authors:  Fuqiong Zhou; Zhengguang Zhang; Meiyuan Wang; Weina Zhu; Jie Ruan; Hongyan Long; Yajie Zhang; Ning Gu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

9.  Paeoniflorin improves functional recovery through repressing neuroinflammation and facilitating neurogenesis in rat stroke model.

Authors:  Hongli Tang; Leiruo Wu; Xixi Chen; Huiting Li; Baojun Huang; Zhenyang Huang; Yiyang Zheng; Liqing Zhu; Wujun Geng
Journal:  PeerJ       Date:  2021-05-28       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.